Acronym | Identity |
---|---|
DOTA-SHALs | |
LePLDDo | 5-Leuenkephalin PEG lysine deoxycholate DOTA |
LeacPLDDo | Acetylated 5-leuenkephalin PEG lysine deoxycholate DOTA |
ItPLDDo | Triiodothyronine PEG lysine deoxycholate DOTA |
DvLPTPLDo | Dabsyl-l-valine lysine PEG l-thyronine PEG lysine DOTA |
DvLPBaPLDo | Dabsyl-l-valine lysine PEG N-benzoyl-l-arginyl-4-amino-benzoic acid PEG lysine DOTA |
DvLPPBaPLDo | Dabsyl-l-valine lysine PEG PEG N-benzoyl-l-arginyl-4-amino-benzoic acid PEG lysine DOTA |
CtLPTPLDo | 3-(2-([3-Chloro-5-trifluoromethyl)-2-pyridinyl]oxy)-anilino)-3-oxopropanionic acid lysine PEG l-thyronine PEG lysine DOTA |
CtLPBaPLDo | 3-(2-([3-Chloro-5-trifluoromethyl)-2-pyridinyl]oxy)-anilino)-3-oxopropanionic acid lysine PEG N-benzoyl-l-arginyl-4-amino-benzoic acid PEG lysine DOTA |
Biotin-SHALs | |
LeLDB | 5-Leuenkephalin lysine deoxycholate biotin |
LePLDB | 5-Leuenkephalin PEG lysine deoxycholate biotin |
LeacPLDB | Acetylated 5-leuenkephalin PEG lysine deoxycholate biotin |
ItPLDB | Triiodothyronine PEG lysine deoxycholate biotin |
DvLPBaPLB | Dabsyl-l-valine lysine PEG N-benzoyl-l-arginyl-4-amino-benzoic acid PEG lysine biotin |
Boldface type indicates the 4 DOTA-SHALs evaluated in mice.